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We studied bispyridinium oxime K203 [(E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyimino methyl-
pyridinium)-but-2-ene dibromide] with tabun-inhibited human acetylcholinesterase (AChE) and 
butyrylcholinesterase (BChE) in vitro, and its antidotal effect on tabun-poisoned mice and rats in vivo. 
We compared it with oximes K048 and TMB-4, which have proven the most effi cient oxime antidotes in 
tabun poisoning by now. Tabun-inhibited AChE was completely reactivated by K203, with the overall 
reactivation rate constant of 1806 L mol-1 min-1. This means that K203 is a very potent reactivator of 
tabun-inhibited AChE. In addition, K203 reversibly inhibited AChE (K
i 
= 0.090 mmol L-1) and BChE 
(K
i 
= 0.91 mmol L-1), and exhibited its protective effect against phosphorylation of AChE by tabun in vitro. 
In vivo, a quarter of the LD
50
 K203 dose insured survival of all mice after the application of as many as 
8 LD
50
 doses of tabun, which is the highest dosage obtained compared to K048 and TMB-4. Moreover, 
K203 showed high therapeutic potency in tabun-poisoned rats, preserving cholinesterase activity in rat 
plasma up to 60 min after poisoning. This therapeutic improvement obtained by K203 in tabun-poisoning 
places this oxime in the spotlight for further development.
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Pyridinium oximes have been investigated for 
many years as compounds with a great potential in 
the treatment of poisoning with organophosphorus 
compounds, including insecticides and nerve agents 
(1). One of the most important actions of oximes is 
that they reactivate acetylcholinesterase (AChE; EC 
3.1.1.7) inhibited by organophosphorus agents. In 
restoring the activity of AChE, oximes may also have 
benefi cial antinicotinic effects (2-4). Current evidence 
indicates that atropine is favourable only in the 
management of acute muscarinic signs and symptoms 
(sweating, salivation, rhinorrhoe, lacrimation, nausea, 
vomiting, and diarrhoea) induced by organophosphates 
(2, 5-7). Although atropine does not readily cross the 
blood-brain barrier, in combination with oximes it is 
the treatment of choice for organophosphate poisoning 
(7, 8). Unfortunately, some organophosphates resist 
standard antidotal treatment (1). One of the most 
dangerous organophosphates is nerve agent tabun. 
The inability of the standard therapy to reactivate 
tabun-phosphorylated AChE may be due to the lower 
electrophilicity of the phosphoroamidate conjugated 
to the AChE active site (9). While oxime HI-6 cannot 
reactivate tabun-inhibited enzyme, although it exerts a 
signifi cant protection via different mechanisms (10), 
HLö-7 can actually reactivate AChE inhibited by all 
four main nerve agents (tabun, sarin, soman and VX). 
Oxime TMB-4 effectively reactivates tabun-inhibited 
AChE, and it also reduces or alleviates the toxic effects 
of tabun, showing benefi cial effects in the treatment 
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of tabun-poisoned animals (1, 11, 12). At the same 
time, TMB-4 is the most toxic oxime of the four most 
investigated oximes 2-PAM, HI-6, obidoxime, and 
TMB-4 (4). Therefore, there is still a need to develop 
not only the most effective, but also the least toxic 
organophosphate antidote.
Recently we obtained promising results on in 
vitro reactivation of human AChE inhibited by tabun 
and antidotal treatment of tabun-poisoned mice with 
bispyridinium oximes (13-18). In this paper we tested 
the reactivation and antidotal potency of bispyridinium 
oxime K203, which is an analogue of the most effi cient 
oxime from our previous studies, K048 (Figure 1) (13, 
14). We determined in vitro kinetic parameters for 
K203 interactions (inhibition and reactivation) with 
native and tabun-inhibited human erythrocyte AChE 
and human plasma butyrylcholinesterase (BChE; EC 
3.1.1.8). BChE was included in the study to evaluate 
oxime interaction with this endogenous bio-scavenger, 
because it could interfere with the reactivation of 
tabun-inhibited AChE. The antidotal effect of K203 
upon tabun-poisoning was studied in mice. Rats were 
used to study temporal and spatial distribution of the 
cholinesterase activity after exposure to tabun.
MATERIAL AND METHODS
Chemicals
Figure 1 shows the structure of oximes 
K203, K048, and TMB-4 and tabun. K203 [(E)-
1-(4-carbamoylpyridinium)-4-(4-hydroxyimino-
methylpyridinium)-but-2-ene dibro mide] was 
prepared as described earlier (19). Tabun [ethyl 
N,N-dimethylphosphoroamidocyanidate] was 
purchased from NC Laboratory, Spiez, Switzerland. 
Acetylthiocholine iodide (ATCh) and 5,5’-dithiobis(2-
nitrobenzoic acid) (DTNB) were purchased from 
Sigma Chemical Co., St. Louis, MO, USA. Atropine 
sulphate was purchased from Kemika, Zagreb, 
Croatia.
Cholinesterases and activity measurement
Intact native human erythrocytes were the 
source of AChE, while the source of BChE was 
native human plasma (usual phenotype). AChE 
and BChE reversible inhibition, protection against 
tabun progressive inhibition, and reactivation of 
tabun-inhibited cholinesterases by K203 were 
measured spectrophotometrically as described 
earlier (13, 14). Kinetic parameters were calculated 
from experimental data obtained in at least three 
experiments using known equations (13-15, 20). We 
evaluated the following kinetic parameters: second-
order rate constant of the non-enzymatic reaction 
(k
NE
), enzyme-oxime dissociation constant (K
i
), 
enzyme-substrate dissociation constant corresponding 
to Michaelis constant (K
m
), protection by oxime 
against phosphorylation in terms of calculated and 





maximum fi rst-order rate constant of reactivation 
(k
max
), phosphorylated enzyme-oxime dissociation 
constant (K
OX




All experiments were done in 0.1 mol L-1 sodium 
phosphate buffer, pH 7.4, at 25 °C. The fi nal plasma 
































Figure 1 Structure of the tested oximes and tabun.
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while the fi nal dilution of erythrocytes was 400 fold. 
Final oxime and ATCh concentrations used in the 
experiments, stated in Table 1, were chosen so that 
the oxime induced ATCh hydrolysis did not interfere 
with the studied interactions (21, 22).
Animals
Male BALB-C mice [(18 to 25) g body weight] 
were purchased from the Institute of Immunology, 
Zagreb, Croatia, while male adult Wistar rats [(240 to 
280) g body weight] were obtained from the Institute 
for Medical Research and Occupational Health, 
Zagreb, Croatia. The animals were kept in Macrolone 
cages under controlled conditions (room temperature 
21 °C, exchanging light and dark cycles every 12 h), 
received standard diet for laboratory rodents, and had 
free access to water. Both mice and rats were randomly 
distributed in groups of four and were deprived of 
food for 24 h before the experiment. This study was 
performed with the approval of the Ethical Committee 
of the Institute for Medical Research and Occupational 
Health, Zagreb, Croatia.
Acute toxicity
Acute intraperitoneal (i.p.) toxicity (LD
50
) for all 
tested oximes was evaluated in mice and rats. It was 
based upon 24 h mortality rates calculated according 
to Thompson (23) and Weil (24). Each LD
50
 was 
evaluated from the results obtained with (4 to 6) 
doses of a given compound (dissolved in water); four 
animals were injected per dose. Whenever the results 
of the experiment allowed, the 95 % confi dence limits 
were estimated from tables described elsewhere (23, 
24).
Therapeutic effect of K203 against tabun poisoning 
in mice
The therapeutic effect of K203 in mice was 
tested by i.p. administration of K203 (¼ of its LD
50
) 
and atropine sulphate (10 mg kg-1) one minute after 
subcutaneous tabun administration. Stock solution of 
3.1x10-2 mol L-1 of tabun was prepared in isopropyl 
alcohol; further dilutions were made in water, 
shortly before use. The antidotal effi cacy of K203 
was expressed as protective index (PI) with 95 % 
confi dence limits, and maximal dose of poison (MDP). 
The PI was the ratio of LD
50
 of tabun with and without 
therapy. The MDP was the highest multiple of the LD
50
 
of tabun, which was fully counteracted (survival of all 
animals) by the administrated therapy.
Treatment with K203 in tabun-poisoned rats
For the temporal and spatial distribution of 
cholinesterase activity, rats received a subcutaneous 
dose of ¾ LD
50
 of tabun (LD
50
=315.5 µg kg-1 body 
weight). The therapeutic efficacy of K203 (¼ of 
its LD
50
 dose, i.p.) was tested as therapy given in 
combination with atropine one minute after tabun 
poisoning. Animals were sacrifi ced using the CO
2
 box 
10 min, 30 min, 60 min, and 24 h after the treatment. 
Blood samples were obtained directly from the heart. 
Brain was also isolated and rinsed with saline. Plasma 
and brain samples were frozen immediately after 
sampling at -20 °C until further processing. Prior to 
enzyme activity measurements, brain samples were 
homogenised (40 mg mL-1) in saline. Plasma samples 
were used untreated.
The activity of cholinesterases in plasma and in brain 
homogenates was determined spectrophotometrically, 
using the method by Ellman et al. (25). All experiments 
were performed in 0.1 mol L-1 phosphate buffer 
(pH 7.4), and enzyme activities were measured in 
the presence of 1.0 mmol L-1 ATCh at 22 °C. The 
measured activity presented total AChE and BChE 
activity in plasma or the brain.
Statistical significance was determined using 
Student’s t-test, and differences were considered 
signifi cant when P<0.05.
RESULTS AND DISCUSSION
In vitro K203 interactions with cholinesterases
A newly introduced oxime K203 was evaluated 
through a series of in vitro experiments with an aim 
to establish its potency to counteract tabun poisoning 
in vivo. We established relevant properties of K203 
using kinetic parameters such as inhibition of native 
and reactivation of tabun-inhibited human erythrocyte 
AChE and human plasma BChE. Summarised results 
are presented in Table 1.
K203 reversibly inhibited both cholinesterases and 
in the studied concentration range of substrate ATCh, 
the binding to the catalytic site of both AChE and BChE 
was competitive. Possible binding to the allosteric site 
could not be determined due to the interference of 
the non-enzymatic reaction between K203 and the 
substrate with enzyme activity measurement (k
NE
 in 
Table 1; 22). K203 showed a signifi cant preference 
for native AChE, which points out its potential to 
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reach the main biological target in vivo in tabun 
poisoning. Among the oximes we tested, the AChE-
oxime dissociation constant, K
i
, of 0.09 mmol L-1, 
shows K203 as a moderate AChE inhibitor (15). This 
fi nding may indicate lower acute toxicity of K203, as 
our previous results have shown that binding affi nity 
in vitro corresponds to toxicity in vivo (13).
We also determined the protective effect of K203 
by measuring progressive AChE inhibition by tabun 
in the absence and in the presence of the oxime in the 
concentration corresponding to K
i
 (Table 1). K203 
halved the rate of AChE inhibition by tabun (PI
exp
), 
which means that if used in pretreatment in vivo, it 
should be able to protect the AChE active site from 
tabun inhibition.
K203-assisted reactivation of tabun-inhibited 
AChE was very efficient. A high percentage of 
reactivation was achieved in a short time, even when 
a lower concentration of K203 was applied. In order 
to get a clearer interpretation of K203 reactivation 
effi cacy, we compared the result with the one obtained 
for the most potent reactivator from our previous 
studies, K048 and TMB-4 as a reference compound 
(13, 14). The overall reactivation rate constant, k
r
, 
of 1806 L mol-1 min-1 sets K203 high above K048 
(k
r 
= 673 L mol-1 min-1) (13) or TMB-4 (k
r 
= 306 L
mol-1 min-1) (20). The main reason for this advantage lies 





=0.07 mmol L-1) and the fast rate 
of the nucleophilic displacement of the phosphoryl-
moiety from the active site serine (k
max
=0.13
min-1). Figure 2 shows the reactivation achieved with 
0.10 mmol L-1 of each oxime in 30 min and the rate of 
reactivation at that concentration (k
obs
). Interestingly, 
the only structural difference between K203 and 
K048, which was the most effi cient oxime in our 
previous studies, is a double bond present in the K203 
linker. However, this double bond could infl uence the 
fl exibility of a linker and the formation of additional 
bonds in the active sites, which in the case of K203 
resulted in an effi cient reactivation.
Like other previously tested oximes, K203 showed 
no signifi cant reactivation of tabun-inhibited BChE 
(14, 16). Even after 20 h, the reactivation maximum 
was only 30 %. This means that the fast K203-assisted 
reactivation of tabun-inhibited AChE would not be 
slowed down by K203 interactions with BChE in 
vivo.
Oxime K203 as antidote in mouse and rat tabun 
poisoning
Table 2 summarises the acute toxicity of the tested 
oximes after intraperitoneal administration. The acute 
toxicity of K203 was almost two times lower in rats 
than in mice. A similar result was obtained for TMB-4. 
This is quite unexpected since our previous experience 
with experimental animals has shown that rats are 
more sensitive to xenobiotics than mice. Oxime K203 
showed lower acute toxicity than TMB-4 in mice, but 
a little higher than TMB-4 in rats. Low toxicity of 
K048 in rats corresponds to its previously determined 
toxicity in mice (13).
In vivo experiments included the evaluation of 
antidotal effi ciency of oxime K203 in tabun-poisoned 
mice. We tested the antidotal effi cacy of K203 at ¼ of 
its LD
50
, and results were compared with our previous 
Table 1  Interactions between bispyridinium para-oxime 
K203 and native and tabun-inhibited human AChE 
and BChE. Constants (mean ± standard errors) and 
protective indices (mean ± standard deviation) were 
calculated from experimental data obtained in at least 
three experiments.
Non-enzymatic reaction of K203 with substrate ATCh
K203 / mmol L-1 ATCh / mmol L-1
0.012 to 1.0 0.05 to 2.0
k
NE
 / L mol-1 min-1 13.1 ± 0.27




/ mmol L-1 0.090 ± 0.012 0.91 ± 0.16
K
m 
/ mmol L-1 0.42 ± 0.071 0.14 ± 0.029
K203 / mmol L-1 0.05 to 0.50 0.50 to 2.0
ATCh / mmol L-1 0.10 to 1.0 0.05 to 0.50
Protection against phosphorylation by tabun
AChE







Reactivation of tabun-inhibited enzymes
AChE BChE
K203 / mmol L-1 0.01 to 1.0 0.10 to 3.0
k
r 
/ L mol-1 min-1 1806 ± 491 1.20 ± 0.50
K
ox
 / mmol L-1 0.072 ± 0.019 2.30 ± 0.80
k
max
 / min-1 0.13 ± 0.01 0.003 ± 0.0005
React
max
 / % 90 30
Time of React
max
20 min 6 h
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fi ndings for oximes K048 and TMB-4 (13, 14). A 
combination therapy with K203 and atropine given 
one minute after tabun poisoning provided particularly 
good protection of mice from tabun-induced seizures 
and from toxic effects associated with muscarinic 
receptors, such as salivation, lacrimation, diarrhea, and 
other secretory activities. The protective index of this 
combined therapy was 9.0 LD
50
, and all experimental 
animals survived at as high tabun dose as 8.0 LD
50
. In 
addition, it considerably lowered tabun-induced acute 
toxicity in mice. Compared to K048 and TMB-4, K203 
seems to be the most effective in tabun-poisoned mice, 
regardless of its relative toxicity. In addition, a good 
reactivating effi cacy of K203 in vitro (cf. Table 1) 
corresponds to its therapeutic effi cacy in mice in vivo 
(cf. Table 3). Therefore, it seems that this compound 
has indeed a therapeutic effect that is related to the 
reactivation of tabun-phosphorylated AChE.
In this study, we extended our in vivo experiments 
to rats, poisoning them with a single sub-lethal 
subcutaneous dose of tabun (¾ of its LD
50
). Signs of 
toxicity such as convulsions, hypersalivation, muscle 
fasciculation, seizures, and fine tremor appeared 
within 5 min to 10 min. Signs of toxicity peaked 15 
min to 60 min after tabun injection. Figure 3 shows the 
effect of K203 combined with atropine on rat plasma 
and brain activity of the cholinesterases. A decrease 
in both plasma and brain was measured in all animals 
administered ¾ LD
50
 of tabun. A combination of 
K203 (in a dose of ¼ of its LD
50
) and atropine (i.p.) 
seems to be effective in restoring the activity of the 
cholinesterases in plasma if administered one minute 
after tabun poisoning. This combination signifi cantly 
increased enzyme activity at 30 min and 60 min 
(P<0.05), in respect to untreated rats poisoned with 
¾ LD
50
 of tabun (Figure 3a). After 6 h, the effect of 
the therapy diminished; enzyme activity in plasma 
was as low as in tabun-poisoned rats, probably due 
to a relatively short oxime blood circulation time 
(28). After 24 h, plasma activities in either poisoned 
or treated rats were high, probably because AChE 
and/or BChE were synthesized de novo, and tabun 
was eliminated from the organism. Interestingly, 
brain AChE activity did not differ significantly 
between poisoned and treated rats (Figure 3b). Due 
to the positive oxime charge and oxime’s limiting 
penetration capacity through the blood-brain barrier, 
Table 2  Acute toxicity (LD
50





 / mg kg-1 
Mice Rats
K203 89.1 (75.7 to 104.9) 168.2 (149.9 to 188.8)
K048 224.8 (154.2 to 328.0)* 238.3 (199.7 to 284.3)
TMB-4 73.5 (56.0 to 96.5)* 178.2 (164.2 to 193.4)
* From ref. 13.






95 % confi dence limit /
µg kg-1
PI MDP
Atropine* 401.0 356.0 to 477.0 1.5 1.0
K203 + atropine 3202.6 2452.3 to 4182.4 9.0 8.0
K048 + atropine* 2853.0 2427.7 to 3352.7 8.0 5.0
TMB-4 + atropine* 2542.0 1759.0 to 3672.0 7.0 5.0
* From ref. 13 (LD
50
 of tabun was 356.6 µg kg-1)
PI - protective index
MDP - maximal dose of tabun
Figure 2  Oxime-assisted reactivation of tabun-inhibited 
human erythrocyte AChE (%) obtained at 30 min 
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K203 was not suffi ciently effective in protecting the 
brain.
In conclusion, all of the results presented here 
demonstrate the high potency of K203 in counteracting 
tabun poisoning and its effectiveness even at lower 
concentrations suitable for human use. The signifi cant 
improvement in the therapy of tabun-poisoned 
experimental models makes K203 a leading antidote 
for tabun poisoning.
Acknowledgement
We wish to thank Jasna Mileković, Marija Kramarić, 
and Mirjana Matašin for technical assistance. This work was 
supported by the Ministry of Science, Education and Sports 
of the Republic of Croatia (Grant No. 022-0222148-2889 
and No. 022-0222148-2139) and by NATO (CBP.EAP.
RIG.981791 and CBP.EAP.CLG 983024).
REFERENCES
1. Dawson RM. Review of oximes available for the treatment 
of nerve agent poisoning. J Appl Toxicol 1994;14:317-31.
2. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, 
Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. 
Evaluation of antidotes for poisoning by organophosphorus 
pesticides. Emerg Med 2000;12:22-37.
3. Sheridan RD, Beeson D, Tattersall JEH. Non-competitive 
block of the human muscle adult nicotinic acetylcholine 
receptor ion channel by the bispyridinium compounds, 
SAD-128 (SAD), toxogonin (TOX) and HI-6. Eur J Neurosci 
2000;12(Suppl. S):36.
4. Stojiljković MP, Jokanović M. Pyridinium oximes: rationale 
for their selection as causal antidotes against organophosphate 
poisonings and current solutions for auto-injectors. Arh Hig 
Rada Toksikol 2006;57:435-43.
5. Shih TM, Koviak TA, Capacio BR. Anticonvulsants for 
poisoning by the organophosphorus compound soman: 
Pharmacological mechanisms. Neurosci Biobehav Rev 
1991;15:349-62.
6. Shih TM, McDonough JH, Koplovitz I. Anticonvulsants for 
soman-induced seizure activity. J Biomed Sci 1999;6:86-
96.
7. Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker 
T, Worek F. Lessons to be learnt from organophosphorus 
pesticide poisoning for the treatment of nerve agent 
poisoning. Toxicology 2007;233:145-54.
8. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, 
Felgenhauer N, Zilker T. Modern strategies in therapy of 
organophosphate poisoning. Toxicol Lett 1999;107:233-9.
9. Eto M. Organic and biological chemistry. In: Zweig G, editor. 
The Organophosphorus Pesticides. Cleveland: CRC Press 
Inc.; 1976. p. 142.
10. Hamilton MG, Lundy PM. HI-6 therapy of soman and 
tabun poisoning in primates and rodents. Arch Toxicol 
1989;63:144-9.
11. Maksimović M, Bošković B, Radović L, Tadić V, Deljac 
V, Binenfeld Z. Antidotal effects of bis-pyridinium-2-
monooxime carbonyl derivatives in intoxications with highly 
toxic organophosphorus compounds. Acta Pharm Jugoslav 
1980;30:151-60.
12. Jokanović M, Maksimović M, Kilibarda V, Jovanović D, 
Savić D. Oxime-induced reactivation of acetylcholinesterase 
inhibited by phosphoramidates. Toxicol Lett 1996;85:35-9.
13. Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča 
K, Kovarik Z. In vitro and in vivo evaluation of pyridinium 
oximes: Mode of interaction with acetylcholinesterase, effect 
on tabun- and soman-poisoned mice and their cytotoxicity. 
Toxicology 2006;219:85-96.
14. Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča 
K, Kovarik Z. Pretreatment with pyridinium oximes improves 
antidotal therapy against tabun poisoning. Toxicology 
2006;228:41-50.
15. Kovarik Z, Čalić M, Bosak A, Šinko G, Jelić D. In 
vitro evaluation of aldoxime interactions with human 
acetylcholinesterase. Croat Chem Acta 2008;81:47-57.
16. Kovarik Z, Čalić M, Šinko G, Bosak A, Berend S, Lucić 
Vrdoljak A, Radić B. Oximes: Reactivators of phosphorylated 
acetylcholinesterase and antidotes in therapy against tabun 
poisoning. Chem Biol Interact 2008;175:173-9.
Figure 3  The effects of K203 given in combination with 
atropine on the activity of cholinesterases in the 
plasma (a) and brain (b) of tabun-poisoned rats. 
Asterisk denotes significantly increased enzyme 
activity in respect to control (P<0.05).
Kovarik Z, et al. K203 AS TABUN ANTIDOTE
Arh Hig Rada Toksikol 2009;60:19-26
25
17. Berend S, Lucić Vrdoljak A, Radić B, Kuča K. New 
bispyridinium oximes: In vitro and in vivo evaluation of their 
biological effi ciency in soman and tabun poisoning. Chem 
Biol Interact 2008;175:413-6.
18. Čalić M, Bosak A, Kuča K, Kovarik Z. Interactions of butane, 
but-2-ene or xylene-like linked bispyridinium para-aldoximes 
with native and tabun-inhibited human cholinesterases. Chem 
Biol Interact 2008;175:305-8.
19. Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore 
F, Kuca K. Design of a potent reactivator of tabun-
inhibited acetylcholinesterase-synthesis and evalua-
tion of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyi-
minomethylpyridinium)-but-2-ene dibromide (K203). J Med 
Chem 2007;50:5514-8.
20. Kovarik Z, Čalić M, Šinko G, Bosak A. Structure-activity 
approach in the reactivation of tabun-phosphorylated human 
acetylcholinesterase with bispyridinium para-oximes. Arh 
Hig Rada Toksikol 2007;58:201-9.
21. Šinko G, Čalić M, Kovarik Z. para- and ortho-Pyridinium 
aldoximes in reaction with acetylcholinesterase. FEBS 
Letters 2006;580:3167-72.
22. Šinko G, Čalić M, Bosak A, Kovarik Z. Limitation of the 
Ellman method: Cholinesterase activity measurement in the 
presence of oximes. Anal Biochem 2007;370:223-7.
23. Thompson WR. Use of moving averages and interpolation to 
estimate median effective dose. Bacteriol Rev 1947;11:115-
45.
24. Weil CS. Tables for convenient calculation of median-
effective dose (LD50 or ED50) and instruction in their use. 
Biometrics 1952;8:249-63.
25. Ellman GL, Courtney KD, Andres VJ, Featherstone 
RM. A new and rapid colorimetric determination of 
acetylcholinesterase activity. Biochem Pharmacol 1960;7:88-
95.
26. Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, 
Pfab R, Flegenhauer N, Zilker T. Cholinesterase status, 
pharmacokinetics and laboratory fi ndings during obidoxime 
therapy in organophosphate poisoned patients. Hum Exp 
Toxicol 1997;16:473-80.
27. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute 
organophosphorus pesticide poisoning: a systemic review of 
clinical trials. Qjm-Mon J Assoc Phys 2002;95:275-83.
28. Kalász H, Hasan MY, Sheen R, Kuča K, Petroianu G, 
Ludányi K, Gergely A, Tekes K. HPLC analysis of K-48 
concentration in plasma. Anal Bioanal Chem 2006;385:1062-
7.
Kovarik Z, et al. K203 AS TABUN ANTIDOTE
Arh Hig Rada Toksikol 2009;60:19-26
26
Sažetak
PROCJENA OKSIMA K203 KAO ANTIDOTA PRI OTROVANJU TABUNOM
Proučavali smo bispiridinijski oksim K203 [(E)-1-(4-karbamilpiridinij)-4-(4-hidroksiiminometilpiridinij)-
but-2-ene dibromid] u uvjetima in vitro - studirajući njegove interakcije s ljudskom acetilkolinesterazom 
(AChE) i butirilkolinesterazom (BChe) inhibiranim tabunom te u uvjetima in vivo - određivanjem njegova 
antidotskog učinka na miševe i štakore otrovane tabunom. Radi usporedbe uključili smo rezultate dobivene 
s oksimima K048 i TMB-4 kao najučinkovitijim oksimima kod otrovanja tabunom.
K203 je potpuno reaktivirao AChE inhibiranu tabunom sa sveukupnom brzinom reaktivacije od 1806 L 
mol-1 min-1 što ga svrstava u najučinkovitije reaktivatore AChE inhibirane tabunom. K203 je reverzibilno 
inhibirao AChE (Ki = 0,090 mmol L-1) i BChE (Ki = 0,91 mmol L-1) pokazujući svoja in vitro zaštitna 
svojstva od inhibicije tabunom. Terapija dozom K203 od ¼ njegove LD
50
 omogućila je preživljavanje svih 
miševa nakon otrovanja dozom tabuna od 8,0 LD
50
. Time je K203 pokazao bolju učinkovitost u usporedbi s 
K048 ili TMB-4. K tome, K203 je značajno zaštitio štakore od otrovanja tabunom kompenzirajući toksični 
učinak tabuna na aktivnost kolinesteraze i do 60 min nakon trovanja. Pokazano poboljšanje terapeutske 
učinkovitosti K203 ističe ovaj oksim pretečom za daljnji razvoj antidota u otrovanju tabunom.
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